Development of a value assessment framework for Health Technology Assessment in rare diseases drugs: insights from a Delphi study in Brazil (2025)
- Authors:
- Autor USP: AGUIAR, PATRICIA MELO - FCF
- Unidade: FCF
- DOI: 10.1017/S0266462324004835
- Subjects: DOENÇAS RARAS; MEDICAMENTO; AVALIAÇÃO DE TECNOLOGIAS DA SAÚDE; SISTEMA ÚNICO DE SAÚDE
- Language: Inglês
- Imprenta:
- Source:
- Título: International Journal of Technology Assessment in Health Care
- ISSN: 0266-4623
- Volume/Número/Paginação/Ano: v. 41, n. 1, p. 1-12, 2025
- Este artigo possui versão em acesso aberto
- URL de acesso aberto
- PDF de acesso aberto
- Versão do Documento: Versão publicada (Published version)
-
Status: Artigo aberto em periódico híbrido (Hybrid Open Access) -
ABNT
BIGLIA, Luiza Vasconcelos et al. Development of a value assessment framework for Health Technology Assessment in rare diseases drugs: insights from a Delphi study in Brazil. International Journal of Technology Assessment in Health Care, v. 41, n. 1, p. 1-12, 2025Tradução . . Disponível em: https://dx.doi.org/10.1017/S0266462324004835. Acesso em: 12 mar. 2026. -
APA
Biglia, L. V., Felippini, A., Ribeiro, T. B., Lima, T. de M., & Aguiar, P. M. (2025). Development of a value assessment framework for Health Technology Assessment in rare diseases drugs: insights from a Delphi study in Brazil. International Journal of Technology Assessment in Health Care, 41( 1), 1-12. doi:10.1017/S0266462324004835 -
NLM
Biglia LV, Felippini A, Ribeiro TB, Lima T de M, Aguiar PM. Development of a value assessment framework for Health Technology Assessment in rare diseases drugs: insights from a Delphi study in Brazil [Internet]. International Journal of Technology Assessment in Health Care. 2025 ; 41( 1): 1-12.[citado 2026 mar. 12 ] Available from: https://dx.doi.org/10.1017/S0266462324004835 -
Vancouver
Biglia LV, Felippini A, Ribeiro TB, Lima T de M, Aguiar PM. Development of a value assessment framework for Health Technology Assessment in rare diseases drugs: insights from a Delphi study in Brazil [Internet]. International Journal of Technology Assessment in Health Care. 2025 ; 41( 1): 1-12.[citado 2026 mar. 12 ] Available from: https://dx.doi.org/10.1017/S0266462324004835 - Economic evaluations on the use of aripiprazole for patients with schizophrenia: a systematic review
- Prevalence of depression and anxiety among pharmacy students: a systematic review
- Does sex affect the efficacy, safety, and quality of life outcomes for patients using angiotensin receptor neprilysin inhibitor, soluble guanylate cyclase stimulators, and cardiac myosin activators in heart failure? a systematic review
- Pharmacist interventions in schizophrenia and bipolar affective disorder: a systematic review and meta-analysis
- Use of medications by patients who are Deaf or Hard of Hearing: Reflections for the promotion of rational use
- Colaboração médico-farmacêutico no manejo de pacientes com diabetes mellitus tipo 2: expectativas e resultados
- Pharmacist participated medication review in different practice settings: service or intervention? an overview of systematic reviews
- Estomatite aftosa recorrente (afta)
- Hiperplasia prostática benigna
- Evaluation of mobile applications focused on the care of patients with anxiety disorders: a systematic review in app stores in Brazil
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
